Fig. 1A summarises the A2AAR density values obtained in lymphocytes from RA patients treated with MTX, anti-TNFα agents or RTX after 0, 3, 6, 9, 12 and 24 months from the treatment start. This evidence concerns the gene TNF and rheumatoid arthritis.